CAI
Caris Life Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CAI fundamentals
Caris Life Sciences (CAI) released its earnings on Nov 5, 2025: revenue was 216.83M (YoY +113.38%), beat estimates; EPS was 0.08 (YoY +103.09%), beat estimates.
Revenue / YoY
216.83M
+113.38%
EPS / YoY
0.08
+103.09%
Report date
Nov 5, 2025
CAI Earnings Call Summary for Q3,2025
- Revenue Supercharge: 113% YoY growth ($720M+ 2025) driven by 121% mol prof services, 18% pharma R&D.
- AI-Powered Margins: 68% gross margin (Q3 2025) vs 43.7% 2024, ASPs up 15% tissue, 18% blood.
- Pipeline Breakthroughs: MRD 96% sensitivity, whole genome early detection enrolling 16,000+ subjects.
- Cash Flow Dominance: $55M free cash flow,3Q25, balance sheet $760M.
- 2025 Outlook: 21-22% clinical growth, 68%+ gross margin target.
- Strategic Wins: 80%+ MRD accuracy, 18% blood ASP growth.
- Pipeline Momentum: Early detection, MRD, pharma R&D expansion.
- Execution Excellence: 68% gross margin, 15% ASP expansion.
- Future Growth: 2025+ pipeline with whole genome sequencing, MRD commercialization.
EPS
Revenue
Revenue & Expenses
CAI has released its 2025 Q3 earnings report, with revenue of 216.83M, reflecting a YoY change of 113.38%, and net profit of 24.32M, showing a YoY change of 135.92%. The Sankey diagram below clearly presents CAI's revenue sources and cost distribution.
Key Indicators
Caris Life Sciences (CAI) key financial stats and ratios, covering profitability, financial health, and leverage.
Caris Life Sciences (CAI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Caris Life Sciences (CAI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Caris Life Sciences (CAI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Caris Life Sciences (CAI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Caris Life Sciences (CAI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Caris Life Sciences do and what are its main business segments?What were the key takeaways from Caris Life Sciences’s earnings call?What is the revenue and EPS growth rate for Caris Life Sciences year over year?Did Caris Life Sciences beat or miss consensus estimates last quarter?What factors drove the changes in Caris Life Sciences's revenue and profit?What is the market's earnings forecast for Caris Life Sciences next quarter?What is Caris Life Sciences's latest dividend and current dividend yield?What is Caris Life Sciences's gross profit margin?
